NASDAQ:EUDA EUDA Health (EUDA) Stock Price, News & Analysis $20.35 +0.45 (+2.26%) Closing price 07/29/2026 03:59 PM EasternExtended Trading$19.98 -0.37 (-1.82%) As of 06:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About EUDA Health Stock (NASDAQ:EUDA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EUDA Health alerts:Sign Up Key Stats Today's Range$19.36▼$20.9550-Day Range$10.61▼$20.3552-Week Range$5.26▼$86.00Volume5,598 shsAverage Volume3,455 shsMarket Capitalization$60.85 millionP/E RatioN/ADividend YieldN/APrice Target$55.00Consensus RatingHold Company Overview EUDA Health, Inc. (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health. EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation. These in-office treatment systems are complemented by a secure digital health platform that enables telehealth consultations, remote patient monitoring and real-time data insights for clinicians, aiming to improve patient adherence and clinical outcomes. The company distributes its devices and digital health services through a hybrid model of direct sales to healthcare practices and partnerships with established medical distributors. While its primary market is in the United States, EUDA Health has initiated market entry programs in select international regions and collaborates with clinical investigators to expand its evidence base. Led by a management team with deep experience in medical device innovation, digital therapeutics and women’s health, EUDA Health continues to pursue regulatory clearances, strategic collaborations and product enhancements. Through ongoing research and development efforts, the company aims to broaden its therapeutic offerings and further integrate its digital platform capabilities within the continuum of care. AI Generated. May Contain Errors. Read More EUDA Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreEUDA MarketRank™: EUDA Health scored higher than 35% of companies evaluated by MarketBeat, and ranked 703rd out of 832 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingEUDA Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialEUDA Health has a consensus price target of $55.00, representing about 170.3% upside from its current price of $20.35.Amount of Analyst CoverageEUDA Health has only been the subject of 2 research reports in the past 90 days.Read more about EUDA Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.17% of the float of EUDA Health has been sold short.Short Interest Ratio / Days to CoverEUDA Health has a short interest ratio ("days to cover") of 4.02.Change versus previous monthShort interest in EUDA Health has recently increased by 58.62%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEUDA Health does not currently pay a dividend.Dividend GrowthEUDA Health does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.33 News SentimentEUDA Health has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for EUDA Health this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added EUDA Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EUDA Health insiders have not sold or bought any company stock.Percentage Held by Institutions4.35% of the stock of EUDA Health is held by institutions.Read more about EUDA Health's insider trading history. Receive EUDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EUDA Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EUDA Stock News HeadlinesEUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products39 minutes ago | globenewswire.comEUDA Health Signs Tri-Party MOU to Develop Next-Generation Oncology Cell TherapiesJuly 28 at 5:11 PM | tipranks.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.July 30 at 1:00 AM | Stansberry Research (Ad)EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell TherapiesJuly 28 at 6:00 AM | globenewswire.comEUDA Health (EUDA) to Announce Quarterly Earnings on TuesdayJuly 27 at 2:40 AM | americanbankingnews.comContrasting Fulgent Genetics (NASDAQ:FLGT) & EUDA Health (NASDAQ:EUDA)July 21, 2026 | americanbankingnews.comNew health risks emerge as Europe’s drug market grows more complex, EU agency warnsJune 9, 2026 | msn.comEUDA Health Restores Nasdaq Compliance After Market Value ShortfallJune 1, 2026 | tipranks.comSee More Headlines EUDA Stock Analysis - Frequently Asked Questions How have EUDA shares performed this year? EUDA Health's stock was trading at $46.20 at the start of the year. Since then, EUDA stock has decreased by 56.0% and is now trading at $20.35. How were EUDA Health's earnings last quarter? EUDA Health Holdings Limited (NASDAQ:EUDA) released its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.44) EPS for the quarter, topping the consensus estimate of ($1.20) by $0.76. The company earned $1.92 million during the quarter, compared to the consensus estimate of $3.90 million. When did EUDA Health's stock split? EUDA Health's stock reverse split on Monday, March 23rd 2026.A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, March 22nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of EUDA Health? Shares of EUDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EUDA Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that EUDA Health investors own include Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN), GT Biopharma (GTBP) and Company Calendar Last Earnings5/05/2026Today7/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 EUDA's financial health is in the Green zone, according to TradeSmith. EUDA has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:EUDA Previous SymbolNASDAQ:LAX CIK1847846 Webeuda.com Phone65-6788-0388Fax65-6788-0068Employees2Year Founded2022Price Target and Rating Average Price Target for EUDA Health$55.00 High Price Target$55.00 Low Price Target$55.00 Potential Upside/Downside+170.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.18 Sales & Book Value Annual Sales$6.82 million Price / Sales8.92 Cash FlowN/A Price / Cash FlowN/A Book Value($2.26) per share Price / Book-9.00Miscellaneous Outstanding Shares2,990,000Free FloatN/AMarket Cap$60.85 million OptionableNot Optionable Beta0.68 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:EUDA) was last updated on 7/30/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredPass by August 7… or wait until 2027?Right now, your phone is recording exactly where you are. It does this roughly every two minutes. Precise coor...Crypto 101 Media | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThe invention Elon called the greatest in historyJeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...Brownstone Research | SponsoredThis Quiet Metals Story Is Starting To Stack UpA small North American mining company just hit 57-for-57 on exploration drilling—and that's only part of the s...i2i Marketing Group, LLC | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUDA Health Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EUDA Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
